Advertisement
Advertisement

DBVT

DBVT logo

DBV Technologies S.A.

13.48
USD
Sponsored
-0.26
-1.89%
Aug 07, 15:59 UTC -4
Closed
exchange

After-Market

13.44

-0.04
-0.33%

DBV Technologies S.A. Profile

About

DBV Technologies SA is a biopharmaceutical company. It develops products and immunotherapies for the diagnosis and treatment of various food allergies, including milk and peanut. The Company delivers biological immunoactive compounds, such as allergens, to the immune system by targeting the antigen-presenting cells present in skin. DBV Technologies SA is headquartered in Bagneux, France.

Info & Links

CEO

Daniel Tass�

Headquarters

107 AVENUE DE LA REPUBLIQUE
CHATILLON, I0 92320, FRANCE

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.dbv-technologies.com

Auditor

Deloitte & Associ�s

Share holders

330

Employees

125

DBV Technologies S.A. Statistics

Valuation Measures

Market Capitalization2

844.33M

Enterprise Value

669.43M

Enterprise Value/EBITDA(ttm)

-3.83

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

159.04

Price to Book(mrq)

4.98

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

100.00%

Operating Margin(ttm)

-3506.53%

Profit Margin(ttm)

-5413.23%

Return on Equity(ttm)

-119.33%

Return on Invested Capital(ttm)

-143.59%

Return on Assets(ttm)

-84.43%

Income Statement

Revenue(ttm)

4.94M

Revenue Per Share(ttm)

0.02

Gross Profit(ttm)

4.94M

EBITDA(ttm)3

-174.76M

Net Income Available to Common(ttm)

-175.95M

Diluted EPS(ttm)

-3.51

Share Statistics

Beta (5Y Monthly)

-0.93

52-Week Change

37.95%

S&P 500 52-Week Change

21.72%

S&P 500 Member

No

Stock Optionable

Yes

Total Shares Outstanding1

296.06M

Dividend Yield

0.00%

Float4

58.59M

% Held by Insiders

1.06%

% Held by Institutions

71.74%

Balance Sheet

Total Cash(mrq)

174.90M

Total Cash Per Share(mrq)

0.59

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

3.72%

Quick Ratio(mrq)

3.72%

Book Value Per Share(mrq)

2.71

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.17

Free Cash Flow(ytd)

-102.50M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement